naloxone Archives - Novusdetox

Talk to a Detox Advisor

Success Stories

naloxone

New FDA Commissioner Scott Gottlieb, MD, says the agency wants to know whether abuse-deterrent prescription opioids "are having their intended impact on limiting abuse and helping to curb the epidemic." To help get a meaningful answer, Gottlieb has called a public meeting for July 10 and 11,…

Read More >
issues paper outlining existing regulatory and public health challenges.

As we reported two weeks ago, the new Commissioner told his first staff meeting that “our greatest immediate challenge is the problem of opioid abuse.” This was followed by the news a week later that the FDA has asked for an abuse-deterrent prescription painkiller, Opana ER, to be taken off the market because it’s been so widely abused.

“Opioid formulations with properties designed to deter abuse are not abuse-proof or addiction-proof,” Gottlieb said in a lengthy statement about expanding the FDA’s role in combating the opioid epidemic. “These drugs can still be abused, particularly orally, and their use can still lead to new addiction.”

However, the Commissioner said, these new formulations “may hold promise” as part of a broad effort to reduce abuse.

“We recognize there is a gap in our understanding of whether these products result in a real world, meaningful decrease in the frequency and patterns of opioid misuse and abuse,” he said. “One thing is clear: We need better scientific information to understand how to optimize our assessment of abuse deterrent formulations.”

In his statement, Gottlieb said that “everyone at the FDA is committed to focusing on all aspects of the epidemic.” As part of this program, a steering committee is being formed to examine “additional regulatory and policy actions to combat this crisis” that can reduce the number of new cases of addiction.

The FDA has just published a paper, FDA Facts: Abuse-Deterrent Opioid Medications, that details the agency’s strong support for abuse deterrence formulations. It says that opioids with abuse-deterrent properties are, as Gottlieb says, “not abuse-proof.” But the agency points out that they are “a step toward products that will help reduce abuse.”

The agency “fully supports efforts to better understand the impact of these products in the real-world setting and develop innovative formulations that have the potential to make abuse of these products more difficult or less rewarding,” the paper says. “The FDA is working with many drug makers to support advancements in this area and help drug makers navigate the regulatory path to market as quickly as possible. In working with industry, the FDA is taking a flexible, adaptive approach to the evaluation and labeling of potentially AD products.”

Here’s a list of the currently approved brand-name abuse-deterrent prescription opioids on the market. No generic versions have yet been approved for abuse-deterrent labeling:

The FDA has approved the following opioids with labeling describing AD properties consistent with the FDA’s Guidance for Industry: Abuse-Deterrent Opioids – Evaluation and Labeling:

  • OxyContin – oxycodone, Purdue Pharma
  • Targiniq ER – oxycodone and naloxone, Purdue Pharma
  • Embeda – morphine and naltrexone, Pfizer Inc.
  • Hysingla ER – hydrocodone, Purdue Pharma
  • MorphaBond – morphine, Daiichi Sankyo, Inc.
  • Xtampza ER – oxycodone, Collegium Pharmaceutical Inc
  • Troxyca ER – oxycodone and naltrexone, Pfizer Inc.
  • Arymo ER – morphine, Egalet Corp.
  • Vantrela ER – hydrocodone, Teva Pharm.
  • RoxyBond  – oxycodone, Inspirion

We can certainly see the popularity of oxycodone – half of the 10 approved formulations are built around that drug. Three are morphine and two are hydrocodone. Three are designed with the antagonists naloxone or naltrexone, the rest with some sort of crush and dissolve resistance.

It does look like the FDA is working hard to be responsive to the opioid epidemic.  Meanwhile we are working hard to help those that want to end their dependency on opioids.

">

President Trump's newly appointed FDA Commissioner, Scott Gottlieb, told his first gathering of agency staff last week that "unquestionably, our greatest immediate challenge is the problem of opioid abuse." Gottlieb said the opioid epidemic is "a public health crisis of staggering human and…

Read More >
Novus is the best way to get your life back as painlessly as possible.

Call to speak to one of our experienced & caring detox advisors today!

After six months of serious negotiations, China has agreed to a fentanyl ban of the production and sale of four variations of the synthetic opioid fentanyl. The killer drug has been pouring into the U.S. illegally from China for years and has been implicated directly in countless overdose…

Read More >

First responder and drug counselors say there’s no doubt that Evzio, an injectable version of the anti-overdose drug Naloxone, has saved thousands of lives. “We've seen it save lives and we've seen those lives get clean,” Kent Runyon of the Novus Medical Detox Center told Channel 2’s…

Read More >

Since 1996, when community-based organizations first began to distribute naloxone, the life-saving drug is estimated to have reversed over 26,000 overdoses. When we add on the lives saved by EMT, ER and police responders using naloxone, the number of lives saved becomes astronomical, but…

Read More >
Novus is the best way to get your life back as painlessly as possible.

Call to speak to one of our experienced & caring detox advisors today!

Thirty-five states and the District of Columbia have filed an antitrust lawsuit alleging that two pharmaceutical Suboxone Drugmaker companies have conspired to keep a cheaper generic version of Suboxone off the market. The lawsuit claims that British drugmaker Indivior, along with a New Jersey…

Read More >

One of Florida’s mayor of Orange County told a Senate subcommittee that she believes the state’s successful campaign to close over a thousand “pill mills” a few years ago helped create the current wave of heroin addiction plaguing Florida. Mayor Teresa Jacobs said she believes that the…

Read More >

Kent Runyon of Novus Detox is interviewed by Behavioral Healthcare regarding the funding for the use of naloxone for…

Read More >
Novus is the best way to get your life back as painlessly as possible.

Call to speak to one of our experienced & caring detox advisors today!

In spite of her best efforts to help her son overcome his addiction, Justin Phillips lost 20-year-old Aaron to a heroin overdose in October, 2013. Countless grief-stricken moms across America have had to face similar unthinkable tragedies like heroin overdose. Only a few manage to turn such a…

Read More >

Two major drugstore chains, CVS and Walgreens, will be offering the opioid overdose-reversal medication naloxone to the public without the need for a prescription in at least 35 states and DC by the end of this year. Under physician-approved protocols, CVS has already established the program in…

Read More >
Email Us

message
SUBSCRIBE to our weekly newsletter